Cardiff Oncology (STU:XE7C) Other Income (Expense) : €0.01 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cardiff Oncology Other Income (Expense)?

Cardiff Oncology's other income expense for the Cardiff Oncology's pretax income for the three months ended in Mar. 2024 was €-0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €0.01 Mil.

Cardiff Oncology Other Income (Expense) Historical Data

The historical data trend for Cardiff Oncology's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Other Income (Expense) Chart

Cardiff Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

0.03

-0.25

0.26

-0.36

-0.09

Cardiff Oncology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-0.10	0.01	0.02	-0.01	-

Cardiff Oncology Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01 Mil.

Cardiff Oncology (STU:XE7C) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Cardiff Oncology (STU:XE7C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (STU:XE7C) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

CRDF:USA XE7C:Germany

Address

11055 Flintkote Avenue, San Diego, CA, USA, 92121

Website

https://www.cardiffoncology.com

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Cardiff Oncology (STU:XE7C) Headlines

No Headlines